Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Sintilimab treatment caused hair loss but led to complete tumor remission.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Upadacitinib improved multiple immune-related conditions in one patient.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Alopecia areata patients have a higher risk of other immune-related diseases.

The T/SHBG ratio may be a useful marker for androgen activity in women with androgenetic alopecia.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Pemphigus patients with alopecia have more severe and treatment-resistant disease.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

The man was diagnosed with lupus and improved with treatment.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

A reliable method was created to measure tamsulosin in human blood.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.